The SH3 domain, but not the catalytic domain, is required for phospholipase C-gamma1 to mediate epidermal growth factor-induced mitogenesis.

Biochemical and Biophysical Research Communications
Zhongjian XieDan Peng

Abstract

Phospholipase C-gamma1 (PLC-gamma1) is a multiple-domain protein and plays an important role in epidermal growth factor (EGF)-induced cell mitogenesis, but the underlying mechanism is unclear. We have previously demonstrated that PLC-gamma1 is required for EGF-induced mitogenesis of squamous cell carcinoma (SCC) cells, but the mitogenic function of PLC-gamma1 is independent of its lipase activity. Earlier studies suggest that the Src homology 3 (SH3) domain of PLC-gamma1 possesses mitogenic activity. In the present study, we sought to determine the role of the SH3 domain of PLC-gamma1 in EGF-induced SCC cell mitogenesis. We examined the effect of overexpression of PLC-gamma1, a catalytically active PLC-gamma1 mutant lacking the SH3 domain or a catalytically inactive PLC-gamma1 mutant lacking the X domain on EGF-induced SCC4 (tongue squamous cell carcinoma) cell mitogenesis. We found that overexpression of PLC-gamma1 enhanced EGF-induced SCC4 cell mitogenesis. This enhancement was abolished by deletion of the SH3 domain but not by deletion of the X catalytic domain. These data suggest that the SH3 domain, but not the catalytic domain, is required for PLC-gamma1 to mediate EGF-induced SCC4 cell mitogenesis.

References

Dec 1, 1991·The Journal of Investigative Dermatology·C K JiangM Blumenberg
Dec 19, 1986·Science·P W MajerusD B Wilson
May 6, 1996·Biochemical and Biophysical Research Communications·M R SmithH F Kung
Jun 13, 1997·The Journal of Biological Chemistry·S G Rhee, Y S Bae
Aug 25, 1997·The Journal of Cell Biology·H q SunH L Yin
Jul 10, 1999·The Journal of Biological Chemistry·Z Xie, D D Bikle
Jul 15, 1999·The International Journal of Biochemistry & Cell Biology·A Wells
Dec 2, 1999·Experimental Cell Research·G Carpenter, Q s Ji
Jan 1, 1993·Trends in Cell Biology·B J Mayer, D Baltimore
Jun 1, 2010·Biochemical and Biophysical Research Communications·Zhongjian XieSally D Pennypacker

❮ Previous
Next ❯

Citations

Aug 9, 2013·Advances in Biological Regulation·Rossano LattanzioMarco Falasca
Jun 19, 2013·Acta Pharmacologica Sinica·Qi Qi, Keqiang Ye
Jul 13, 2017·Journal of the American Heart Association·Dongyang JiangJinjiang Pang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.